You are here

  • Home
  • Archive
  • Volume 9, Issue 2
  • Success and failure of additional immune modulators in steroid-refractory/resistant pneumonitis related to immune checkpoint blockade

Article info

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
Success and failure of additional immune modulators in steroid-refractory/resistant pneumonitis related to immune checkpoint blockade

Authors

  • Jason Beattie Pulmonary Division, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USADepartment of Medicine, Weill Cornell Medical College, New York, NY, USA PubMed articlesGoogle scholar articles
  • Hira Rizvi Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York City, New York, USA PubMed articlesGoogle scholar articles
  • Paige Fuentes Pulmonary Division, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA PubMed articlesGoogle scholar articles
  • Jia Luo Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA PubMed articlesGoogle scholar articles
  • Adam Schoenfeld Department of Medicine, Weill Cornell Medical College, New York, NY, USAThoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA PubMed articlesGoogle scholar articles
  • I-Hsin Lin Department of Epidemiology and Biostatistics, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA PubMed articlesGoogle scholar articles
  • Michael Postow Department of Medicine, Weill Cornell Medical College, New York, NY, USAMelanoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA PubMed articlesGoogle scholar articles
  • Margaret Callahan Department of Medicine, Weill Cornell Medical College, New York, NY, USAMelanoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA PubMed articlesGoogle scholar articles
  • Martin H Voss Department of Medicine, Weill Cornell Medical College, New York, NY, USAGenitourinary Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA PubMed articlesGoogle scholar articles
  • Neil J Shah Department of Medicine, Weill Cornell Medical College, New York, NY, USAGenitourinary Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA PubMed articlesGoogle scholar articles
  • Allison Betof Warner Department of Medicine, Weill Cornell Medical College, New York, NY, USAMelanoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA PubMed articlesGoogle scholar articles
  • Mohit Chawla Pulmonary Division, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USADepartment of Medicine, Weill Cornell Medical College, New York, NY, USA PubMed articlesGoogle scholar articles
  • Matthew D Hellmann Department of Medicine, Weill Cornell Medical College, New York, NY, USAThoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Matthew D Hellmann; hellmanm{at}mskcc.org
View Full Text

Citation

Beattie J, Rizvi H, Fuentes P, et al
Success and failure of additional immune modulators in steroid-refractory/resistant pneumonitis related to immune checkpoint blockade
Journal for ImmunoTherapy of Cancer 2021;9:e001884. doi: 10.1136/jitc-2020-001884

Publication history

  • Accepted December 11, 2020
  • First published February 10, 2021.
Online issue publication 
November 23, 2023

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.